Abstract
Get full access to this article
View all access options for this article.
References
1.
Wouters
OJ
Berenbrok
LA
He
M
Li
Y
Hernandez
I
. Association of research and development investments with treatment costs for new drugs approved from 2009 to 2018 . JAMA Network Open . 2022 ;5 (9 ):e2218623.
2.
Dusetzina
SB
Huskamp
HA
. Impending relief for medicare beneficiaries—the Inflation Reduction Act . N Engl J Med . 2022 ;387 (16 ):1437 -1439 .
3.US Food and Drug Administration . Novel drug approvals for 2021 . Accessed January 2, 2023 . https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021
4.US Food and Drug Administration . Novel drug approvals for 2022 . Accessed January 2, 2023 . https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022
5.
6.Red Book Online . IBM micromedex [database online]; 2023 . Accessed June 18, 2023 .
7.
Mattingly
J
. Understanding drug pricing . US Pharm . 2012 ;37 (6 )(Generic Drug Review suppl):40 -45 .